Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable way to predict who will develop it or when. Unlike conditions such as coronary ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
-
-
Sept. 8, 2025 — Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) technology, has announced that the U.S. Food and Drug ...
-
Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at elevated risk for cardiovascular disease.1 Yet arrhythmias like atrial fibrillation (AFib), which are one of the biggest ...
-
May 21, 2025 — Corify Care recently announced it has entered into a know-how agreement with Mayo Clinic. Corify Care is an AI-driven medical technology company specializing in global cardiac mapping ...
Feature | Atrial Fibrillation | Jeffrey Olgin, M.D.
Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable ...
September 12, 2025
Sept. 8, 2025 — Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation ...
September 08, 2025
Sept. 8, 2025 — AMO Pharma Ltd., a clinical-stage specialty biopharmaceutical company focusing on rare genetic ...
September 08, 2025Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at elevated risk for cardiovascular disease.1 Y ...
September 04, 2025
July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...
July 09, 2025
June 13, 2025 — An international study has shown that targeted online education on atrial fibrillation (AF) for health ...
June 16, 2025Sponsored Content
Blog
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
November 13, 2023
June 4, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...
June 04, 2025
May 21, 2025 — Corify Care recently announced it has entered into a know-how agreement with Mayo Clinic. Corify Care is ...
May 22, 2025
April 25, 2025 – Medtronic plc, a global leader in healthcare technology, recently received U.S. Food and Drug ...
April 29, 2025Sponsored Content
Blog
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
November 02, 2023
April 27, 2025 – The Heart Rhythm Society (HRS) has announced the findings of new studies demonstrating the safety and ...
April 28, 2025
April 24, 2025 – The Heart Rhythm Society (HRS) has unveiled new research that underscores the critical role of ...
April 25, 2025
April 23, 2025 – The Heart Rhythm Society (HRS) has released a framework outlining criteria for establishing an Atrial ...
April 23, 2025Sponsored Content
Blog | ECG
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 24, 2022
April 7, 2025 — CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S ...
April 08, 2025
March 29, 2025 — Anthos Therapeutics, Inc., presented two new analyses from its AZALEA-TIMI 71 study at the American ...
March 31, 2025
Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial ...
March 12, 2025© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now